HC Wainwright & Co. Initiates Coverage On Instil Bio with Buy Rating, Announces Price Target of $2
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Mitchell Kapoor has initiated coverage on Instil Bio (NASDAQ:TIL) with a Buy rating and a price target of $2.
June 29, 2023 | 10:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Instil Bio (NASDAQ:TIL) has been initiated with a Buy rating by HC Wainwright & Co. with a price target of $2.
The initiation of coverage by HC Wainwright & Co. with a Buy rating and a price target of $2 indicates a positive outlook for Instil Bio. This could potentially attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100